 |
2012 Inhalation and Nasal Technology Focus Group (INTFG) Annual Fall Symposium – Hosted by Gateway Analytical
September 7, 2012
Pittsburgh, Pennsylvania
Royal Pharmaceutical Society Annual Conference 2012
September 9, 2012–September 10, 2012
Birmingham, United Kingdom
2012 PDA/FDA Joint Regulatory Conference
September 10, 2012–September 12, 2012
Baltimore, Maryland
World Drug Safety Congress Europe 2012
September 11, 2012–September 13, 2012
London, United Kingdom
FDA/DIA Biosimilars Conference: Guidances, Science, and BsUFA
September 12, 2012–September 13, 2012
Washington, DC
|
|
|
 |
 
 |
 |
Pfizer and Mylan Partner to Develop Generic Drugs in Japan
Pfizer and Mylan have agreed to establish an exclusive long-term collaboration to develop, manufacture, distribute, and market generic drugs in Japan. The products included in the collaboration are expected to be sold under the Pfizer brand with joint labeling.
The Foundation for the National Institute of Health Seeks Public Comment
The Observational Medical Outcomes Partnership, which is managed by the Foundation, is seeking feedback on proposed research priorities and tasks.
Advertisement:
Handheld Raman Accelerates Raw Material Release
Enwave Optronics introduces the NEW ASSUPx Handheld Raman Analyzer for raw material verification. Most materials are measured and evaluated within 15 seconds. The ASSUPx is fully 21 CFR Part 11 compliant for GMP requirements. It is an ideal choice for pharmaceutical, industrial chemicals and applications requiring high speed, reliable Raman analysis
Enwave Optronics, Inc.
 http://www.enwaveopt.com/EZRaman-H.htm |
EMA Deals with Manufacturing Deficiencies for Cancer Medicine
The European Medicines Agency has recommended that the anticancer medicine DepoCyte be recalled from EU countries following the discovery of manufacturing deficiencies at Pacira Pharmaceuticals' San Diego site.
Advertisement:
Ropack provides solid dose packaging services to leading pharmaceutical and healthcare companies. Operating in 250,000 square feet, Ropack is equipped for humidity- and temperature-sensitive production and packaging of stick-packs. Other services include blister, bottle and pouch, powder blending and encapsulation and in-country clinical trial packaging and distribution management. Ropack has the capacity, technology and resources to grow your business. Contact:paul.dupont@ropack.com
 Read More |
PhRMA Research Awards Focus on Alzheimer's Disease
On Sept. 12, 2012, PhRMA is cohosting a brand new national awards program in Washington, DC, to honor individuals and organizations that have contributed significantly to the fight against Alzheimer’s Disease.
Advertisement:
Realize Effective Pharmaceuticals
Reliable solutions enable pharmaceutical scientists to innovate in disease research, accelerate drug discovery and have greater confidence throughout development and manufacturing. Agilent solutions in genomics research, automation, separation and detection technologies along with workflow driven software solutions helps deliver the answers to bring effective therapeutics to market.
Learn more at  www.agilent.com/lifesciences/realizepharma |
|
CPhI Worldwide is the world’s leading pharmaceutical networking event for Pharma Ingredients. Along with co-located events ICSE for Contract Services, InnoPack for Innovative Packaging and P-MEC Europe for Technology, Equipment and Machinery, this is a one-stop shop event that cannot be missed by anyone serving the (Bio)Pharmaceutical industry.
First launched in 1990, the events have grown to a scope of 2,200 exhibitors and 30,000+ attendees from over 140 countries. An ideal networking platform, CPhI and co-located events allow you to meet all your business partners under one roof!
CPhI and co-located events host zones for each area of Pharma. From APIs to Generics, from Fine Chemicals to Intermediates and Finished Dosage, Custom Manufacturing and Clinical Trials, Transportation, Lab Devices, Track and Trace and much more.
Where else in the world can you find this many companies, showcasing their innovations, looking to meet people just like you?
CPhI and co-located events host zones for each area of Pharma. From APIs to Generics, from Fine Chemicals to Intermediates and Finished Dosage, Custom Manufacturing and Clinical Trials, Transportation, Lab Devices, Track and Trace and much more.
Drop by from October 9–11, 2012 in Feria de Madrid, Spain. Admission is free of charge when you register online in advance, but a special VIP pass is also available against a small fee. With this VIP pass, gain access to the VIP lounge, which includes refreshments and free Wifi access, the exhibitor party and CPhI Pharma Awards ceremony and more. Please visit our website for more information about our packages and their advantages
Register online now. We look forward to seeing you there!
|
 Wet mill improves API milling capabilities
The Quadro Ytron HV combines inline emulsification and wet mill capabilities in one machine, and offers more than 55 times the high shear energy of conventional rotor–stator systems with precise process scaling from laboratory formulation, to pilot and production processing. Other pharmaceutical applications for the machine include the development of submicron emulsions (high shear homogenizing with a droplet size = 0.2–1 µm), drug suspensions (high shear wet milling with a particle size = 1–10 µm), and topical formulations and semisolids (droplet/particle size = 0.4–3 µm). The HV-Series features three different models ranging from 7.5–60 horsepower with capacities ranging from 1–285 L/min.
|
|
|
 |
|
AstraZeneca has appointed Pascal Soriot as CEO and executive director of the company’s board of directors, effective Oct. 1, 2012. Simon Lowth will remain as AstraZeneca’s interim CEO until Pascal Soriot joins. At that point, Simon Lowth will resume his responsibilities as chief financial officer and will continue to serve as an executive director on the board. Read More
Advertisement:
Advances in Label-Free Technology (Video) –  Click to Watch
Watch this customer success story as told by GSK in this video. Learn how you too can unlock challenging targets, simplify assay design, and shorten time to results with the Agilent RapidFire System. In this video, GSK presents the findings from their studies using the RapidFire High-throughput Mass Spectrometry System in various stages of the lead discovery process.
Re-Imagine Mass Spectrometry Throughput Watch the Video |
Eli Lilly announced that the US Court of Appeals for the Federal Circuit has affirmed a prior ruling by the US District Court for the District of Delaware that the company’s compound patent for Alimta (pemetrexed) is valid. The compound patent provides protection for Alimta in the US through January 2017. Read More
Advertisement:
FDA Drug Development and Compliance
This continually updated CfPA course covers current FDA drug development issues and compliance with respect to marketing human drugs and biologics, including NDAs, ANDAs and other pre-approval documents, the FD&C Act, case law, and the FDA’s authority to promulgate and enforce regulations. September 19-20 New Brunswick, NJ. Use Priority Code PT200 and Save $200.  Read More |
The Merck Group has agreed to acquire Biochrom, a German company that specializes in the production and marketing of cell-culture media and buffer solutions. The acquisition is expected to close in the fourth quarter of 2012, and is subject to customary closing conditions and regulatory approval. Read More
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers. Read More
Advertisement:
Risk Management in Sterile Manufacturing
LIVE WEBCAST: Thursday, September 27, 2012 from 2:00 PM - 3:00 PM EDT
Register Free at  http://www.pharmtech.com/dpt2 |
Do you have news to report on facility expansions, contracts, service agreements, mergers, acquisitions, or personnel appointments? Send press releases to ptpress@advanstar.com |
|
|
|
 |
| CROs and CMOs Have Cause to Celebrate |
by: Jim Miller
The 2012 edition of the PharmSource–PharmTech Outsourcing Survey shows strong growth for service providers and promises to continue into 2013. This article is part of a special issue on outsourcing.
|
Coming soon: Pharm Tech’s September issue contains an report from MIT on product quality and development based on a history outcomes survey. |
|
|
|
Know Before You Go—2012 Conference Previews
Visit our Show & Exhibition Gateway 2012 to see which companies are exhibiting at upcoming industry conferences.
Find company backgrounds, new product releases, booth materials, and more.
PharmTech's online
Gateway is your guide to the season's leading shows.
|
|
|
|
|
|
